| __timestamp | MiMedx Group, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 12665000 | 9216000000 |
| Thursday, January 1, 2015 | 20202000 | 8296000000 |
| Friday, January 1, 2016 | 32407000 | 10044000000 |
| Sunday, January 1, 2017 | 35219000 | 11560000000 |
| Monday, January 1, 2018 | 36386000 | 10558000000 |
| Tuesday, January 1, 2019 | 43081000 | 9351000000 |
| Wednesday, January 1, 2020 | 39330000 | 8933000000 |
| Friday, January 1, 2021 | 43283000 | 8284000000 |
| Saturday, January 1, 2022 | 48316000 | 7952000000 |
| Sunday, January 1, 2023 | 54634000 | 8200000000 |
| Monday, January 1, 2024 | 8480000000 |
Data in motion
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial for investors and stakeholders. This analysis delves into the cost of revenue trends for Teva Pharmaceutical Industries Limited and MiMedx Group, Inc. from 2014 to 2023. Over this period, Teva's cost of revenue has shown a downward trend, decreasing by approximately 14% from its peak in 2017. In contrast, MiMedx has experienced a steady increase, with costs rising by over 330% since 2014.
This comparative analysis highlights the contrasting financial strategies of these two companies, offering valuable insights into their operational efficiencies and market positioning.
Analyzing Cost of Revenue: Pfizer Inc. and MiMedx Group, Inc.
Cost Insights: Breaking Down Amgen Inc. and Teva Pharmaceutical Industries Limited's Expenses
Cost of Revenue: Key Insights for Regeneron Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Limited
Cost of Revenue: Key Insights for Teva Pharmaceutical Industries Limited and Dr. Reddy's Laboratories Limited
Comparing Cost of Revenue Efficiency: Teva Pharmaceutical Industries Limited vs Bio-Techne Corporation
Cost Insights: Breaking Down Teva Pharmaceutical Industries Limited and Telix Pharmaceuticals Limited's Expenses
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Xenon Pharmaceuticals Inc.
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Bausch Health Companies Inc.
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Mesoblast Limited
Selling, General, and Administrative Costs: Teva Pharmaceutical Industries Limited vs MiMedx Group, Inc.
Analyzing Cost of Revenue: PTC Therapeutics, Inc. and MiMedx Group, Inc.
Cost of Revenue: Key Insights for Supernus Pharmaceuticals, Inc. and MiMedx Group, Inc.